These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 25504022
21. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K. Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [Abstract] [Full Text] [Related]
23. Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma. Chung HH, Cheon GJ, Kim JW, Park NH, Song YS. Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):47-55. PubMed ID: 28828510 [Abstract] [Full Text] [Related]
25. Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings. Inubashiri E, Hata K, Kanenishi K, Shiota A, Ohno M, Yamamoto Y, Nishiyama Y, Ohkawa M, Hata T. J Obstet Gynaecol Res; 2009 Feb; 35(1):26-34. PubMed ID: 19215544 [Abstract] [Full Text] [Related]
26. SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients. Antonsen SL, Loft A, Fisker R, Nielsen AL, Andersen ES, Høgdall E, Tabor A, Jochumsen K, Fagö-Olsen CL, Asmussen J, Berthelsen AK, Christensen IJ, Høgdall C. Gynecol Oncol; 2013 May; 129(2):298-303. PubMed ID: 23376805 [Abstract] [Full Text] [Related]
28. Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases. Stecco A, Buemi F, Cassarà A, Matheoud R, Sacchetti GM, Arnulfo A, Brambilla M, Carriero A. Radiol Med; 2016 Jul; 121(7):537-45. PubMed ID: 27033474 [Abstract] [Full Text] [Related]
34. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer. Lee DH, Kim SH, Joo I, Hur BY, Han JK. Eur J Radiol; 2016 Jun; 85(6):1085-91. PubMed ID: 27161056 [Abstract] [Full Text] [Related]
35. Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of 18FDG PET-CT. Legros M, Margueritte F, Tardieu A, Deluche E, Mbou VB, Lacorre A, Ceuca A, Aubard Y, Monteil J, Sallee C, Gauthier T. Anticancer Res; 2019 Feb; 39(2):619-625. PubMed ID: 30711937 [Abstract] [Full Text] [Related]
36. Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT. Kara T, Kara PO, Gedik GK, Sari O. Rev Esp Med Nucl Imagen Mol; 2012 Feb; 31(1):31-3. PubMed ID: 21737185 [Abstract] [Full Text] [Related]
38. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF. J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [Abstract] [Full Text] [Related]
39. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer. Shim SH, Kim DY, Lee DY, Lee SW, Park JY, Lee JJ, Kim JH, Kim YM, Kim YT, Nam JH. BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772 [Abstract] [Full Text] [Related]
40. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K. Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]